BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 38128546)

  • 21. Varying time-course of effects of high frequency stimulation of sub-regions of the globus pallidus in patients with parkinson's disease.
    Angeli A; Akram H; Zacharia A; Limousin P; Hariz M; Zrinzo L; Foltynie T
    Parkinsonism Relat Disord; 2015 Jun; 21(6):597-602. PubMed ID: 25842261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.
    Mossner JM; Patil PG; Chou KL
    J Neural Transm (Vienna); 2019 Nov; 126(11):1479-1483. PubMed ID: 31494731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term motor outcomes of deep brain stimulation of the globus pallidus interna in Parkinson's disease patients: Five-year follow-up.
    Hwang YS; Jo S; Lee SH; Kim N; Kim MS; Jeon SR; Chung SJ
    J Neurol Sci; 2023 Jan; 444():120484. PubMed ID: 36463584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson's disease.
    Oyama G; Foote KD; Jacobson CE; Velez-Lago F; Go C; Limotai N; Zeilman PR; Romrell J; Wu SS; Neal D; Okun MS
    Parkinsonism Relat Disord; 2012 Aug; 18(7):814-8. PubMed ID: 22525365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
    Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. White matter connectivity of subthalamic nucleus and globus pallidus interna targets for deep brain stimulation.
    DiRisio AC; Avecillas-Chasin JM; Platt S; Jimenez-Shahed J; Figee M; Mayberg HS; Choi KS; Kopell BH
    J Neurosurg; 2023 Nov; 139(5):1366-1375. PubMed ID: 37119111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
    Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
    BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Bocci T; Prenassi M; Arlotti M; Cogiamanian FM; Borellini L; Moro E; Lozano AM; Volkmann J; Barbieri S; Priori A; Marceglia S
    NPJ Parkinsons Dis; 2021 Sep; 7(1):88. PubMed ID: 34584095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship Between Iron Distribution in Deep Gray Matter Nuclei Measured by Quantitative Susceptibility Mapping and Motor Outcome After Deep Brain Stimulation in Patients With Parkinson's Disease.
    Zhao W; Yang C; Tong R; Chen L; Chen M; Gillen KM; Li G; Ma C; Wang Y; Wu X; Li J
    J Magn Reson Imaging; 2023 Aug; 58(2):581-590. PubMed ID: 36594513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of subthalamic nucleus deep brain stimulation and dopaminergic treatment on dual-task manual dexterity in Parkinson's disease.
    Gülşen Ç; Koçer B; Çomoğlu SS; Gündüz AG
    Neurol Sci; 2023 May; 44(5):1633-1641. PubMed ID: 36598618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep brain stimulation of globus pallidus internus and subthalamic nucleus in Parkinson's disease: a multicenter, retrospective study of efficacy and safety.
    Mainardi M; Ciprietti D; Pilleri M; Bonato G; Weis L; Cianci V; Biundo R; Ferreri F; Piacentino M; Landi A; Guerra A; Antonini A
    Neurol Sci; 2024 Jan; 45(1):177-185. PubMed ID: 37555874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
    Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
    J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson's disease.
    Radcliffe EM; Baumgartner AJ; Kern DS; Al Borno M; Ojemann S; Kramer DR; Thompson JA
    J Neurophysiol; 2023 Jun; 129(6):1492-1504. PubMed ID: 37198135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
    Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological effects of dual target DBS in an individual with Parkinson's disease and a sensing-enabled pulse generator.
    Cummins DD; Sandoval-Pistorius SS; Cernera S; Fernandez-Gajardo R; Hammer LH; Starr PA
    Parkinsonism Relat Disord; 2024 May; 122():106089. PubMed ID: 38460490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.